-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Reiterates Overweight on Organogenesis Holdings, Maintains $7 Price Target

Benzinga·07/15/2025 12:46:51
Listen to the news
Cantor Fitzgerald analyst Ross Osborn reiterates Organogenesis Holdings (NASDAQ:ORGO) with a Overweight and maintains $7 price target.